Literature DB >> 10833074

Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for)

F Shanahan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10833074     DOI： 10.1097/00054725-200005000-00011

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

1.  Production and Purification of a Novel Anti-TNF-α Single Chain Fragment Variable Antibody.

Authors:  Ali Akbar Alizadeh; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-12-31

2.  Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Authors:  Ida Ricciardelli; Keith J Lindley; Marco Londei; Sonia Quaratino
Journal:  Immunology       Date:  2008-04-16       Impact factor: 7.397

3.  Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology.

Authors:  Ali Akbar Alizadeh; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2015-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.